HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $6
BenzingaFeb 29 15:21 ET
Lyell Immunopharma Analyst Ratings
BenzingaFeb 29 15:19 ET
HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $8
BenzingaNov 9, 2023 07:38 ET
Lyell Immunopharma Analyst Ratings
BenzingaNov 9, 2023 07:37 ET
Promising Financial and Clinical Prospects: A Comprehensive Buy Rating Analysis for Lyell Immunopharma
TipRanksNov 9, 2023 06:46 ET
JP Morgan Cuts Lyell to Neutral, Pending Data for Cell Therapy Platform
Seeking AlphaAug 28, 2023 17:41 ET
JP Morgan Downgrades Lyell Immunopharma to Neutral, Lowers Price Target to $5
BenzingaAug 28, 2023 04:48 ET
Lyell Immunopharma Analyst Ratings
BenzingaAug 28, 2023 04:47 ET
H.C. Wainwright Reaffirms Their Buy Rating on Lyell Immunopharma (LYEL)
TipRanksAug 9, 2023 06:35 ET
HC Wainwright & Co. Reiterates Buy on Lyell Immunopharma, Maintains $9 Price Target
BenzingaMay 5, 2023 06:54 ET
Lyell Immunopharma (LYEL) Receives a Buy From H.C. Wainwright
TipRanksMay 5, 2023 06:37 ET
HC Wainwright Adjusts Price Target on Lyell Immunopharma to $9 From $11, Maintains Buy Rating
MT NewswiresMar 2, 2023 07:38 ET
Morgan Stanley Adjusts Lyell Immunopharma's Price Target to $4 From $7, Maintains Equal Weight Rating
MT NewswiresJan 24, 2023 11:40 ET
Morgan Stanley Sticks to Its Hold Rating for Lyell Immunopharma (LYEL)
TipRanksJan 24, 2023 11:30 ET
Lyell Immunopharma Analyst Ratings
Benzinga Analyst RatingsJan 24, 2023 09:04 ET
Morgan Stanley Maintains Equal-Weight on Lyell Immunopharma, Lowers Price Target to $4
Benzinga Real-time NewsJan 24, 2023 09:04 ET
Lyell Immunopharma Analyst Ratings
Benzinga Analyst RatingsNov 14, 2022 06:22 ET
Morgan Stanley Downgrades Lyell Immunopharma to Equal-Weight, Lowers Price Target to $7
Benzinga Real-time NewsNov 14, 2022 06:22 ET
Lyell Immunopharma Analyst Ratings
Benzinga Analyst RatingsNov 11, 2022 13:27 ET
Lyell Immunopharma Analyst Ratings
Benzinga Analyst RatingsOct 17, 2022 06:23 ET
No Data
No Data